title: Enhanced IL-18 expression in common skin tumors.
abstract: Interleukin-18 (IL-18) has been found to have multiple effects upon various cells involved in inflammatory response. Recently we reported that B16 murine melanoma cells are able to produce IL-18, which is involved in the regulation of intracellular reactive oxygen intermediates (ROI) and Fas-ligand expression, indicating that IL-18 plays key role in the tumor activity of melanoma. In this study, we investigated the pattern of IL-18 expression in the human system. IL-18 production was tested by enzyme linked immunosorbent assay (ELISA) assay in various tumor cell lines, including Raji (Burkitt's lymphoma), IM-9 (B lymphoblast), Jurkat (acute T cell leukemia), SK-MES-1 (squamous cell carcinoma (SCC) cell line), SK-MEL-2, G-361, DM-4, and DX-3 (melanoma cell lines). ELISA tests showed that IL-18 was highly expressed in malignant skin tumors such as SK-MES-1, SK-MEL-2, G-361, DM-4, and DX-3 cell lines, thus suggesting that IL-18 production may be associated with the malignancy of skin tumors. Here, we report that enhanced IL-18 expression is positively correlated with malignant skin tumors such as SCC and melanoma, suggesting the importance role of IL-18 in malignancy of skin tumors. Taken together, expression of IL-18 by tumor cells in human skin tissue may provide an important clue to understand the pathogenesis of malignant skin tumors.
authors.affiliation: Department of Dermatology, St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
authors.forename: H
authors.initials: H
authors.lastname: Park
authors.forename: D
authors.initials: D
authors.lastname: Byun
authors.forename: T S
authors.initials: TS
authors.lastname: Kim
authors.forename: Y I
authors.initials: YI
authors.lastname: Kim
authors.forename: J S
authors.initials: JS
authors.lastname: Kang
authors.forename: E S
authors.initials: ES
authors.lastname: Hahm
authors.forename: S H
authors.initials: SH
authors.lastname: Kim
authors.forename: W J
authors.initials: WJ
authors.lastname: Lee
authors.forename: H K
authors.initials: HK
authors.lastname: Song
authors.forename: D Y
authors.initials: DY
authors.lastname: Yoon
authors.forename: C J
authors.initials: CJ
authors.lastname: Kang
authors.forename: C
authors.initials: C
authors.lastname: Lee
authors.forename: D
authors.initials: D
authors.lastname: Houh
authors.forename: H
authors.initials: H
authors.lastname: Kim
authors.forename: B
authors.initials: B
authors.lastname: Cho
authors.forename: Y
authors.initials: Y
authors.lastname: Kim
authors.forename: Y H
authors.initials: YH
authors.lastname: Yang
authors.forename: K H
authors.initials: KH
authors.lastname: Min
authors.forename: D H
authors.initials: DH
authors.lastname: Cho
mesh_terms: D002280:Basal Cell Carcinoma / Q000276:immunology / Q000378:metabolism; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000378:metabolism; D017077:Culture Media, Conditioned / Q000494:pharmacology; D004797:Enzyme-Linked Immunosorbent Assay; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D007371:Interferon-gamma / Q000096:biosynthesis; D020382:Interleukin-18 / Q000096:biosynthesis* / Q000276:immunology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000378:metabolism; D008545:Melanoma / Q000276:immunology / Q000378:metabolism; D012878:Skin Neoplasms / Q000276:immunology / Q000378:metabolism*; D014407:Tumor Cells, Cultured
chemical_list: D017077:Culture Media, Conditioned; D020382:Interleukin-18; D007371:Interferon-gamma